LIFECORE BIOMEDICAL, INC. Capital Expenditures Incurred but Not yet Paid
LIFECORE BIOMEDICAL, INC. (LFCR) reported Capital Expenditures Incurred but Not yet Paid of $306.00 thousand for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-05.
Financial Statements › Cash Flow › Other Cash Flow Items
us-gaap:CapitalExpendituresIncurredButNotYetPaid · last filed 2026-08-05
- LIFECORE BIOMEDICAL, INC. capital expenditures incurred but not yet paid for the quarter ending 2026-06-30 was $155.00K.
- LIFECORE BIOMEDICAL, INC. capital expenditures incurred but not yet paid for the quarter ending 2026-03-31 was $151.00K.
- LIFECORE BIOMEDICAL, INC. capital expenditures incurred but not yet paid for the quarter ending 2025-09-30 was $420.00K.
- LIFECORE BIOMEDICAL, INC. capital expenditures incurred but not yet paid for the quarter ending 2025-05-25 was -$104.00K, a 104.29% decline year-over-year.
- LIFECORE BIOMEDICAL, INC. capital expenditures incurred but not yet paid for fiscal 2025 was $1.54M, a 80.41% decline from fiscal 2024.
- LIFECORE BIOMEDICAL, INC. capital expenditures incurred but not yet paid for fiscal 2024 was $7.86M, a 13.15% increase from fiscal 2023.
- LIFECORE BIOMEDICAL, INC. capital expenditures incurred but not yet paid for fiscal 2023 was $6.95M, a 207.30% increase from fiscal 2022.
- LIFECORE BIOMEDICAL, INC. capital expenditures incurred but not yet paid for fiscal 2022 was $2.26M, a 52.16% decline from fiscal 2021.
| Period end | Capital Expenditures Incurred but Not yet Paid 3 month | Capital Expenditures Incurred but Not yet Paid 6 month | Capital Expenditures Incurred but Not yet Paid 7 month | Capital Expenditures Incurred but Not yet Paid 9 month | Capital Expenditures Incurred but Not yet Paid 9 month as first filed | Capital Expenditures Incurred but Not yet Paid 12 month | Capital Expenditures Incurred but Not yet Paid 12 month as first filed |
|---|---|---|---|---|---|---|---|
| 2026-06-30 | $155.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-05 | $306.00K 10-Q · filed 2026-08-05 | |||||
| 2026-03-31 | $151.00K 10-Q · filed 2026-05-06 | ||||||
| 2025-12-31 | $778.00K 10-KT · filed 2026-03-16 | ||||||
| 2025-09-30 | $420.00K 10-Q · filed 2025-11-06 | ||||||
| 2025-05-25 | -$104.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-05 | $1.54M 10-Q · filed 2026-08-05 | $1.33M derived: sum of 3 quarters · filed 2026-08-05 | $1.54M 10-KT · filed 2026-03-16 | |||
| 2025-02-23 | $1.64M 10-Q · filed 2026-05-06 | $1.44M derived: sum of 2 quarters · filed 2026-05-06 | $1.64M 10-Q · filed 2025-04-03 | $9.77M derived: sum of 4 quarters · filed 2026-05-06 | |||
| 2024-11-24 | -$206.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2025-01-02 | $5.70M 10-Q · filed 2025-01-02 | $8.13M derived: sum of 3 quarters · filed 2026-03-16 | $5.43M derived: sum of 4 quarters · filed 2026-03-16 | |||
| 2024-08-25 | $5.91M 10-Q · filed 2025-11-06 | $8.33M derived: sum of 2 quarters · filed 2026-03-16 | $5.63M derived: sum of 3 quarters · filed 2026-03-16 | $9.02M derived: sum of 4 quarters · filed 2026-03-16 | |||
| 2024-05-26 | $2.42M derived: 10-KT 12 month − 10-Q 9 month · filed 2026-03-16 | -$274.00K derived: sum of 2 quarters · filed 2026-03-16 | $3.12M derived: sum of 3 quarters · filed 2026-03-16 | $7.86M 10-KT · filed 2026-03-16 | |||
| 2024-02-25 | -$2.70M derived: 10-Q 9 month − 10-Q 6 month · filed 2025-04-03 | $692.00K derived: sum of 2 quarters · filed 2025-04-03 | $5.43M 10-Q · filed 2025-04-03 | $8.46M derived: sum of 4 quarters · filed 2025-04-03 | |||
| 2023-11-26 | $3.39M derived: 10-Q 6 month − 10-Q 3 month · filed 2025-01-02 | $8.13M 10-Q · filed 2025-01-02 | $11.16M derived: sum of 3 quarters · filed 2025-01-02 | $12.38M derived: sum of 4 quarters · filed 2025-01-02 | |||
| 2023-08-27 | $4.74M 10-Q · filed 2024-10-04 | $7.77M derived: sum of 2 quarters · filed 2024-10-04 | $8.99M derived: sum of 3 quarters · filed 2024-10-04 | $9.44M derived: sum of 4 quarters · filed 2024-10-04 | |||
| 2023-05-28 | $3.03M derived: 10-K 12 month − 10-Q 9 month · filed 2024-08-26 | $4.25M derived: sum of 2 quarters · filed 2024-08-26 | $4.70M derived: sum of 3 quarters · filed 2024-08-26 | $6.95M 10-K · filed 2024-08-26 | |||
| 2023-02-26 | $1.22M derived: 10-Q 9 month − 10-Q 6 month · filed 2024-08-09 | $1.68M derived: sum of 2 quarters · filed 2024-08-09 | $3.92M 10-Q · filed 2024-08-09 | $4.41M derived: sum of 4 quarters · filed 2024-08-26 | |||
| 2022-11-27 | $457.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-09 | $2.70M 10-Q · filed 2024-08-09 | $3.20M derived: sum of 3 quarters · filed 2024-08-26 | $3.85M derived: sum of 4 quarters · filed 2024-08-26 | |||
| 2022-08-28 | $2.24M 10-Q · filed 2024-08-09 | $2.74M derived: sum of 2 quarters · filed 2024-08-26 | $3.40M derived: sum of 3 quarters · filed 2024-08-26 | $2.51M derived: sum of 4 quarters · filed 2024-08-26 | |||
| 2022-05-29 | $496.00K derived: 10-K 12 month − 10-K 9 month · filed 2024-08-26 | $1.16M derived: sum of 2 quarters · filed 2024-08-26 | $266.00K derived: sum of 3 quarters · filed 2024-08-26 | $2.26M 10-K · filed 2024-08-26 | |||
| 2022-02-27 | $659.00K derived: 10-K 9 month − 10-K 6 month · filed 2024-03-20 | -$230.00K derived: sum of 2 quarters · filed 2024-03-20 | $1.76M 10-K · filed 2024-03-20 | $1.76M 10-Q · filed 2022-04-07 | $5.36M derived: sum of 4 quarters · filed 2024-03-20 | ||
| 2021-11-28 | -$889.00K derived: 10-K 6 month − 10-K 3 month · filed 2024-03-20 | $1.10M 10-K · filed 2024-03-20 | $4.71M derived: sum of 3 quarters · filed 2024-03-20 | $4.30M derived: sum of 4 quarters · filed 2024-03-20 | |||
| 2021-08-29 | $1.99M 10-K · filed 2024-03-20 | $5.59M derived: sum of 2 quarters · filed 2024-03-20 | $5.19M derived: sum of 3 quarters · filed 2024-03-20 | $5.74M derived: sum of 4 quarters · filed 2024-03-20 | |||
| 2021-05-30 | $3.60M derived: 10-K 12 month − 10-K 9 month · filed 2024-03-20 | $3.20M derived: sum of 2 quarters · filed 2024-03-20 | $3.75M derived: sum of 3 quarters · filed 2024-03-20 | $4.72M 10-K · filed 2024-03-20 | |||
| 2021-02-28 | -$402.00K derived: 10-K 9 month − 10-Q 6 month · filed 2024-03-20 | $146.00K derived: sum of 2 quarters · filed 2024-03-20 | $1.12M 10-K · filed 2024-03-20 | $2.15M derived: sum of 4 quarters · filed 2024-03-20 | |||
| 2020-11-29 | $548.00K derived: 10-Q 6 month − 10-K 3 month · filed 2022-01-07 | $1.53M 10-Q · filed 2022-01-07 | $2.55M derived: sum of 3 quarters · filed 2024-03-20 | $1.17M derived: sum of 4 quarters · filed 2024-03-20 | |||
| 2020-08-30 | $978.00K 10-K · filed 2024-03-20 | $2.00M derived: sum of 2 quarters · filed 2024-03-20 | $624.00K derived: sum of 3 quarters · filed 2024-03-20 | $1.61M derived: sum of 4 quarters · filed 2024-03-20 | |||
| 2020-05-31 | $1.03M derived: 10-K/A 12 month − 10-Q 9 month · filed 2023-03-16 | -$354.00K derived: sum of 2 quarters · filed 2023-03-16 | $629.00K derived: sum of 3 quarters · filed 2023-03-16 | $2.82M 10-K/A · filed 2023-03-16 | |||
| 2020-02-23 | -$1.38M derived: 10-Q 9 month − 10-Q 6 month · filed 2021-04-08 | -$398.00K derived: sum of 2 quarters · filed 2021-04-08 | $1.79M 10-Q · filed 2021-04-08 | $2.71M derived: sum of 4 quarters · filed 2021-07-29 | |||
| 2019-11-24 | $983.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2021-01-07 | $3.17M 10-Q · filed 2021-01-07 | $4.09M derived: sum of 3 quarters · filed 2021-07-29 | $5.80M derived: sum of 4 quarters · filed 2021-07-29 | |||
| 2019-08-25 | $2.19M 10-Q · filed 2020-10-07 | $3.10M derived: sum of 2 quarters · filed 2021-07-29 | $4.82M derived: sum of 3 quarters · filed 2021-07-29 | $3.02M derived: sum of 4 quarters · filed 2021-07-29 | |||
| 2019-05-26 | $913.00K derived: 10-K 12 month − 10-Q 9 month · filed 2021-07-29 | $2.63M derived: sum of 2 quarters · filed 2021-07-29 | $830.00K derived: sum of 3 quarters · filed 2021-07-29 | $3.95M 10-K · filed 2021-07-29 | |||
| 2019-02-24 | $1.72M derived: 10-Q 9 month − 10-Q 6 month · filed 2020-04-03 | -$83.00K derived: sum of 2 quarters · filed 2020-04-03 | $3.04M 10-Q · filed 2020-04-03 | $9.30M derived: sum of 4 quarters · filed 2020-08-14 | |||
| 2018-11-25 | -$1.80M derived: 10-Q 6 month − 10-Q 3 month · filed 2020-01-02 | $1.32M 10-Q · filed 2020-01-02 | $7.59M derived: sum of 3 quarters · filed 2020-08-14 | $7.39M derived: sum of 4 quarters · filed 2020-08-14 | |||
| 2018-08-26 | $3.12M 10-Q · filed 2019-10-03 | $9.38M derived: sum of 2 quarters · filed 2020-08-14 | $9.19M derived: sum of 3 quarters · filed 2020-08-14 | $10.76M derived: sum of 4 quarters · filed 2020-08-14 | |||
| 2018-05-27 | $6.27M derived: 10-K 12 month − 10-Q 9 month · filed 2020-08-14 | $6.07M derived: sum of 2 quarters · filed 2020-08-14 | $7.65M derived: sum of 3 quarters · filed 2020-08-14 | $8.45M 10-K · filed 2020-08-14 | $8.45K 10-K · filed 2018-08-09 | ||
| 2018-02-25 | -$196.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2019-04-04 | $1.38M derived: sum of 2 quarters · filed 2019-04-04 | $2.18M 10-Q · filed 2019-04-04 | ||||
| 2017-11-26 | $1.57M derived: 10-Q 6 month − 10-Q 3 month · filed 2019-01-07 | $2.37M 10-Q · filed 2019-01-07 | |||||
| 2017-08-27 | $799.00K 10-Q · filed 2018-10-05 | ||||||
| 2017-05-28 | $4.38M 10-K · filed 2019-08-01 | $4.38K 10-K · filed 2018-08-09 | |||||
| 2016-05-29 | $4.79K 10-K · filed 2018-08-09 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| ADC Therapeutics SA (ADCT) | $0.163B | -1.39 | |
| Minerva Neurosciences, Inc. (NERV) | United States | $0.165B | -0.66 |
| Tonix Pharmaceuticals Holding Corp. (TNXP) | United States | $0.166B | -1.34 |
| Annexon, Inc. (ANNX) | United States | $0.147B | -4.22 |
| Corbus Pharmaceuticals Holdings, Inc. (CRBP) | United States | $0.144B | -1.72 |
| Organogenesis Holdings Inc. (ORGO) | United States | $0.182B | -3.70 |
| SPRUCE BIOSCIENCES, INC. (SPRB) | United States | $0.142B | -2.89 |
| Korro Bio, Inc. (KRRO) | United States | $0.141B | -1.81 |
| AN2 Therapeutics, Inc. (ANTX) | United States | $0.185B | -4.84 |
| Atrium Therapeutics, Inc. (RNA) | United States | $0.140B |